I'm not sure if this specific article has been posted here before. However, I've posted several similar articles by Samuel Sherratt, Mason, Libby, Bhatt et.al. along these topics. Any thoughts that these giants in the field have abandoned their positions about VASCEPA and EPA as an effective agent in the treatment of many indications should not be entertained. Nissen has been totally rebuffed. Yes,
News 
Market Data 
Discover 
